The National Eye Institute Awards Five Year Grant For Rare Eye Disease Research
source: pixabay.com

The National Eye Institute Awards Five Year Grant For Rare Eye Disease Research

According to a story from Health News and Information, The National Eye Institute presented Juergen Naggert, Ph.D.,  with a grant in order to study genetically connected changes that occur in…

Continue Reading The National Eye Institute Awards Five Year Grant For Rare Eye Disease Research
The Results of This Clinical Trial Could Be Important For Familial Hypercholesterolemia Patients
stevepb / Pixabay

The Results of This Clinical Trial Could Be Important For Familial Hypercholesterolemia Patients

According to a story from Bioportfolio, trials testing the treatment inclisiran are reaching their enrollment goals ahead of schedule. Inclisiran is currently being tested to reduce LDL-cholesterol in a variety…

Continue Reading The Results of This Clinical Trial Could Be Important For Familial Hypercholesterolemia Patients
A Recent Study Could Reveal A New Once-A-Week Treatment For Short Bowel Syndrome
source: pixabay.com

A Recent Study Could Reveal A New Once-A-Week Treatment For Short Bowel Syndrome

According to an article from GlobeNewswire, new clinical evidence supports the use of gelpaglutide as a once-weekly treatment for short bowel syndrome. Zealand Pharma completed a Phase I clinical trial…

Continue Reading A Recent Study Could Reveal A New Once-A-Week Treatment For Short Bowel Syndrome
The Results of this Study Could Improve Outcomes for Duchenne Muscular Dystrophy
source: pixabay.com

The Results of this Study Could Improve Outcomes for Duchenne Muscular Dystrophy

Last month, the pharmaceutical company Sarepta Therapeutics announced the long awaited results of a study that measured lung function in patients with Duchenne muscular dystrophy (DMD) after they took eteplirsen,…

Continue Reading The Results of this Study Could Improve Outcomes for Duchenne Muscular Dystrophy
These Rare Disease Treatments Just Became a Lot More Affordable for Australians
source: pixabay.com

These Rare Disease Treatments Just Became a Lot More Affordable for Australians

The Australian government has announced that almost that new treatments worth $300 million are being added to the Pharmaceutical Benefits Scheme. This program provides subsidized medical treatments to citizens of…

Continue Reading These Rare Disease Treatments Just Became a Lot More Affordable for Australians
Medical Professionals Are Starting To Debate Clinical Trial Eligibility Standards
source: pixabay.com

Medical Professionals Are Starting To Debate Clinical Trial Eligibility Standards

According to an article from the Chicago Tribune, many medical specialists are coming to the realization that the eligibility criteria for clinical trials should be reassessed. The problem is that…

Continue Reading Medical Professionals Are Starting To Debate Clinical Trial Eligibility Standards
The European Commission Just Approved MVASI, One of The First Biosimilar Cancer Drugs
source: pixabay.com

The European Commission Just Approved MVASI, One of The First Biosimilar Cancer Drugs

According to an article from PRNewswire, the drug MVASI (biosimilar bevacizumab) was just granted marketing authorization by the European Commission. Developed by Amgen and Allergan, this treatment has been approved…

Continue Reading The European Commission Just Approved MVASI, One of The First Biosimilar Cancer Drugs